Diversified Trust CO Clovis Oncology, Inc. Transaction History

Diversified Trust CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$0.63 - $2.96 $10,233 - $48,079	-16,243 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$4.81 - $10.34 $8,042 - $17,288	-1,672 Reduced 9.33%	16,243 $114,000
Q4 2020 Jan 08, 2021	BUY	$4.13 - $6.41 $73,988 - $114,835	17,915 New	17,915 $86,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.